It sounds a little like science fiction — take a pill at home and your doctor is notified. Nevertheless, this may be the future of medicine and it’s been approved by the U.S. Food and Drug Administration. It was November 13, 2017, when the FDA announced the approval of the first digital pill — Abilify… Read More »
A study has concluded that HIV self-testing is safe, increases testing uptake and increases the yield of HIV positive results among men who have sex with men (MSM) and transgender people. Among female sex workers, results are more mixed. While HIV self-testing improves testing uptake, it does not increase the yield of positive results and… Read More »
Preventing unwanted pregnancy and HIV infection by using one product could be a reality one day. Early research on several products presented last week at the virtual HIV Research for Prevention (HIVR4P) conference showed that they are safe and that potential users are attracted by the idea of a two-in-one prevention method. High rates of… Read More »
There remains a substantial gap throughout Europe between the need and desire for HIV pre-exposure prophylaxis (PrEP) and the number of people actually using it, an online workshop convened towards the end of last year by the European AIDS Clinical Society (EACS) heard. The workshop on PrEP was the second part of its fourth Standard… Read More »